Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 3991 AL 4005

Carbon-based nanotechnology for Parkinson's disease: diagnostic and therapeutic innovations

Lafi Z, Asha S, Asha SY.

Nanomedicine (Lond). 2025 Aug;20(16):2023-2041. doi: 10.1080/17435889.2025.2535940. Epub 2025 Jul 23.

Green, innovative oral capsules of three anti-Parkinson's drugs: formulation, in vitro evaluation, and robust RP-HPLC validation

Mahgoub SM, Alawam AS, Rudayni HA, Allam AA, Ezzat KH, Elsuccary SAA, Radalla AM, Mahmoud R.

Anal Methods. 2025 Jul 31;17(30):6215-6230. doi: 10.1039/d5ay00698h.

Precision targeting of the CNS: recent progress in brain-directed nanodrug delivery

Senanayake D, Yapa P, Dabare S, Munaweera I.

RSC Adv. 2025 Jul 21;15(32):25910-25928. doi: 10.1039/d5ra03578c. eCollection 2025 Jul 21.

The Identification and Challenges of Dopamine Dysregulation Syndrome: A Case Report

Sulaiman A, Leppla I.

Cureus. 2025 Jun 22;17(6):e86547. doi: 10.7759/cureus.86547. eCollection 2025 Jun.

Protein Misfolding and Aggregation as a Mechanistic Link Between Chronic Pain and Neurodegenerative Diseases

Brezic N, Gligorevic S, Sic A, Knezevic NN.

Curr Issues Mol Biol. 2025 Apr 8;47(4):259. doi: 10.3390/cimb47040259.

The Expanding Role of GLP-1 Receptor Agonists: Advancing Clinical Outcomes in Metabolic and Mental Health

Al Qassab M, Mneimneh M, Jradi A, Derbas B, Dabboussi D, Khoury Baini J, Katrib N, Chaarani N, Attieh P, Kanaan A, Harb F, Azar S, Ghadieh HE.

Curr Issues Mol Biol. 2025 Apr 17;47(4):285. doi: 10.3390/cimb47040285.

Exploring the potential of repurposed deferoxamine: bridging challenges and novel formulation opportunities

Mukherjee S, Reddy A, Dutta N, Vaiphei KK, Vivek, Kumar A, Gulbake A.

Nanomedicine (Lond). 2025 Aug;20(16):2117-2141. doi: 10.1080/17435889.2025.2534318. Epub 2025 Jul 23.

Long-Term Outcomes of Chenodeoxycholic Acid Therapy for Cerebrotendinous Xanthomatosis: A Nationwide Study on Prognostic Factors and Treatment Response

Zubarioglu T, Kadıoğlu-Yılmaz B, Köse E, Teke-Kısa P, Balcı MC, Yazıcı H, Özturk-Hişmi B, Akgün A, Kor D, Yıldız S, Kılıç-Yıldırım G, Soyuçen E, Akçalı A, Yıldız Y, Durmuş A, Güneş D, Soylu-Üstkoyuncu P, Kasapkara ÇS, Erdöl Ş, Göksoy E, Akar HT, Gümüş H, Ekmekçi AH, Eminoğlu FT, Arslan N, Hanağası HA, Canda E, Genç E, Özer I, Gündüz A, Kıykım E, Aktuğlu-Zeybek Ç.

J Inherit Metab Dis. 2025 Jul;48(4):e70069. doi: 10.1002/jimd.70069.

Synthetic microneurotrophins: Neurotrophin receptors for therapeutics of neurodegenerative diseases

Zota I, Calogeropoulou T, Chanoumidou K, Charalampopoulos I, Gravanis A.

Br J Pharmacol. 2025 Oct;182(19):4466-4489. doi: 10.1111/bph.70143. Epub 2025 Jul 23.

Unmet needs in the pharmacological management of motor symptoms in Parkinson's disease

Heim B, Poewe W.

J Parkinsons Dis. 2025 Jul 23:1877718X251352416. doi: 10.1177/1877718X251352416. Online ahead of print.

Protein regulatory network mediated by palmitoylation modifications in the pathological progression of Parkinson's disease: a narrative review

Liu J, Wang S, Fan L, Zhou X, Zhang S, Wang Q, Dong P, Yu B.

Front Immunol. 2025 Jul 9;16:1615001. doi: 10.3389/fimmu.2025.1615001. eCollection 2025.

Regulation of BBB function and pathological evolution of PD by microenvironment "spatiotemporal gradient": unique advantages of microfluidic chips

Yu S, Jiang L, Song M, Yang T, Yuan M, Chen X, Shu H.

Front Aging Neurosci. 2025 Jul 9;17:1599509. doi: 10.3389/fnagi.2025.1599509. eCollection 2025.

Implications of mtDNA in human health and diseases

Seethashankar S, Hariharan S, Parvathi VD.

BioTechnologia (Pozn). 2025 Jun 30;106(2):209-222. doi: 10.5114/bta/204532. eCollection 2025.

The contributing role of CCR5 in dementia

Zheng T, Ye M, Zhou P.

Front Neurol. 2025 Jul 9;16:1545302. doi: 10.3389/fneur.2025.1545302. eCollection 2025.

Subcutaneous Foslevodopa as Rescue Therapy for Abrupt Interruption of Oral Dopaminergic Treatment in Parkinson's Disease

Ory-Magne F, Houeto JL, Fabbri M.

Mov Disord Clin Pract. 2025 Dec;12(12):2382-2385. doi: 10.1002/mdc3.70253. Epub 2025 Jul 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias